5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC

NCT05317000 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma of Head and Neck

Interventions

DRUG: Combination 5-azacytidine and nivolumab
DRUG: 5-azacytidine
DRUG: Nivolumab

Sponsor

Barbara Burtness

Collaborators

[object Object]